Cargando…
Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
Monoamine oxidase inhibitors (MAOIs) are an important class of drugs prescribed for treatment of depression and other neurological disorders. Evidence has suggested that patients with atypical depression preferentially respond to natural product MAOIs. This review presents a comprehensive survey of...
Autores principales: | Chaurasiya, Narayan D., Leon, Francisco, Muhammad, Ilias, Tekwani, Babu L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268457/ https://www.ncbi.nlm.nih.gov/pubmed/35807542 http://dx.doi.org/10.3390/molecules27134297 |
Ejemplares similares
-
Selective Interactions of O-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
por: Chaurasiya, Narayan D., et al.
Publicado: (2020) -
Monoamine Oxidase Inhibitory Constituents of Propolis: Kinetics and Mechanism of Inhibition of Recombinant Human MAO-A and MAO-B
por: Chaurasiya, Narayan D., et al.
Publicado: (2014) -
Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from Turnera diffusa (Damiana)
por: Chaurasiya, Narayan D., et al.
Publicado: (2019) -
Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B
por: Chaurasiya, Narayan D., et al.
Publicado: (2017) -
Enantioselective Interactions of Anti-Infective 8-Aminoquinoline Therapeutics with Human Monoamine Oxidases A and B †
por: Chaurasiya, Narayan D., et al.
Publicado: (2021)